| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 37.461 | 59.159 | 68.330 | 99.255 |
| Total Income - EUR | - | - | - | - | - | - | 37.461 | 59.159 | 68.330 | 99.255 |
| Total Expenses - EUR | - | - | - | - | - | - | 8 | 6.905 | 26.276 | 48.725 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 37.452 | 52.254 | 42.054 | 50.531 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 36.329 | 50.856 | 41.371 | 47.586 |
| Employees | - | - | - | - | - | - | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Endodiahealth S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 644 | 75.780 | 65.953 |
| Current Assets | - | - | - | - | - | - | 36.820 | 50.858 | 77.314 | 119.371 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 0 | 46.580 | 46.388 | 62.712 |
| Cash | - | - | - | - | - | - | 36.820 | 4.278 | 30.926 | 36.555 |
| Shareholders Funds | - | - | - | - | - | - | 36.369 | 50.905 | 92.121 | 139.192 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 450 | 597 | 60.972 | 46.132 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Endodiahealth S.r.l.